Navigation Links
Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders

Kennedy Krieger Institute Research Confirms Parent and Physician Reports that Children with Autism Spectrum Disorders Exhibit Fewer Autistic-like Behaviors during Illness with Fever

BALTIMORE, Dec. 3 /PRNewswire-USNewswire/ -- Over the past few decades, parents and clinicians have observed that the behaviors of children with autism spectrum disorders (ASD) tend to improve, sometimes rather dramatically, during a fever. Longer concentration spans, increased language production, improved eye contact and better overall relations with adults and peers have all been reported. In a study published today in the journal Pediatrics, researchers from the Kennedy Krieger Institute in Baltimore, Maryland confirmed, for the first time, parent and clinician reports that the behavior of children with ASD improves with fever. The study evaluated children with ASD during and after an episode of fever and found that fewer autistic-like behaviors were recorded for children with fever compared to controls. Understanding how fever affects the behaviors of children with ASD may provide insight into the causes of the disorder and potential treatment opportunities.

In typically developing children, signals are constantly being sent through pathways that connect the different regions of the brain and allow them to communicate with one another. Research has shown that these connections between brain regions are not made in children with autism, which limits their ability to communicate and socialize. But, the rapid behavioral changes observed with the onset of fever in children with ASD suggest that the different regions of the brain are in fact capable of connecting and communicating with one another, and that something about the fever state triggers or speeds up the signaling between brain regions. Understanding this "fever effect," including why and how connections are made between brain regions during a febrile (fever) state and not in an afebrile (without fever) state in children with ASD may provide valuable insight into the neurological basis of the disorder.

"Since autism spectrum disorders are behaviorally defined and diagnosed, studying changes in behavior resulting from a wide range of physiological changes is critical to increasing our understanding of this complex group of disorders," said Andrew Zimmerman, Director of Medical Research at the Center for Autism and Related Disorders at the Kennedy Krieger Institute. "The results of this study are important because they show us that the autistic brain is plastic, or capable of altering current connections and forming new ones in response to different experiences or conditions."

Researchers evaluated 30 children with ASD, ages two to 18 years, during and after an episode of fever (fever was defined as 100.4 degrees F/38.0 degrees C or greater). Parents were asked to observe their child's actions and complete a standardized behavior questionnaire at three different points: during fever; when the fever subsided and the child was asymptomatic; and when the child was fever-free for seven days. These data were compared to data collected from parents of 30 afebrile children with ASD who made up the control group. Children in the control group were matched to children in the fever group in terms of age, sex and language skills. Results revealed fewer autistic-like behaviors for children with fever compared to controls, with more than 80 percent of fever subjects showing some behavioral improvements and approximately 30 percent exhibiting dramatic improvements.

"Pilot research studies such as this provide clues about the underlying metabolic changes in the brain that may prove to be targets for novel autism therapies," said Dr. Gary Goldstein, President and CEO of Kennedy Krieger Institute. "These and other similar findings are shaping the future direction of autism research."

Further research involving a larger participant pool is needed to better understand fever-specific effects in autism. In the future, Dr. Zimmerman would like to collaborate with other research institutions to study the underlying biologic mechanisms of fever-specific effects in autism by conducting blood tests during and after fever and analyzing immune measurements and hormonal changes in the blood. This research study was the work of senior author Dr. Andrew Zimmerman of the Kennedy Krieger Institute and the doctoral thesis of Laura Curran at Johns Hopkins Bloomberg School of Public Health and the Kennedy Krieger Institute. The study was funded by Cure Autism Now, which merged with the organization Autism Speaks in 2007.

Pediatrics is an official peer-reviewed journal of the American Academy of Pediatrics, publishing original research, clinical observations, and special feature articles in the field of pediatrics. The journal has been continuously published by the American Academy of Pediatrics since January 1948.

About Autism

Autism spectrum disorders (ASD) is the nation's fastest growing developmental disorder, with current incidence rates estimated at 1 in 150 children. This year more children will be diagnosed with autism than AIDS, diabetes and cancer combined, yet profound gaps remain in our understanding of both the causes and cures of the disorder. Continued research and education about developmental disruptions in individuals with ASD is crucial, as early detection and intervention can lead to improved outcomes in individuals with ASD.

About the Kennedy Krieger Institute

Internationally recognized for improving the lives of children and adolescents with disorders and injuries of the brain and spinal cord, the Kennedy Krieger Institute in Baltimore, MD serves more than 13,000 individuals each year through inpatient and outpatient clinics, home and community services and school-based programs. Kennedy Krieger provides a wide range of services for children with developmental concerns mild to severe, and is home to a team of investigators who are contributing to the understanding of how disorders develop while pioneering new interventions and earlier diagnosis. For more information on Kennedy Krieger Institute, visit

SOURCE Kennedy Krieger Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 25, 2015 USP 800 applies to ... (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician assistants, ... chapter also covers all entities which store, prepare, ... other healthcare institutions, patient treatment clinics, physicians, practice ... --> What is the purpose ...
(Date:11/25/2015)... Asia -based venture ... and the New Investors will make a direct equity ... private placement. The financing will help IOPtima to continue ... in the treatment of glaucoma, as well as to ... system with the U.S. Food and Drug Administration, commencing ...
Breaking Medicine Technology:
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in ... on several models of traditional and far-infrared saunas. , For traditional saunas, ... the most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
Breaking Medicine News(10 mins):